Decoy Therapeutics Inc. Financing Cash Flow
Decoy Therapeutics Inc. (DCOY) reported Financing Cash Flow of $3.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
- Decoy Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.16M.
- Decoy Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Decoy Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $6.07M.
- Decoy Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $5.86M, a 328.51% increase year-over-year.
- Decoy Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2025 was $12.34M, a 1064.00% increase from fiscal 2024.
- Decoy Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2024 was $1.06M, a 84.04% decline from fiscal 2023.
- Decoy Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2023 was $6.64M, a 234.09% increase from fiscal 2022.
- Decoy Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2022 was $1.99M, a 92.98% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 1 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 4 month | Net Cash Provided by (Used in) Financing Activities 4 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 10 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $3.16M 10-Q · filed 2026-08-12 | $9.23M derived: sum of 3 quarters · filed 2026-08-12 | $15.10M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $6.07M derived: sum of 2 quarters · filed 2026-05-08 | $11.93M derived: sum of 3 quarters · filed 2026-05-08 | $11.79M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-12-31 | $6.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $11.93M derived: sum of 2 quarters · filed 2026-03-31 | $11.79M derived: sum of 3 quarters · filed 2026-08-12 | $12.34M 10-K · filed 2026-03-31 | ||||||||
| 2025-09-30 | $5.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.72M derived: sum of 2 quarters · filed 2026-08-12 | $6.27M 10-Q · filed 2025-11-14 | $6.16M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-06-30 | -$141.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $404.37K 10-Q · filed 2026-08-12 | $297.39K derived: sum of 3 quarters · filed 2026-08-12 | $1.67M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||
| 2025-03-31 | $545.57K 10-Q · filed 2026-05-08 | $438.58K derived: sum of 2 quarters · filed 2026-05-08 | $1.81M derived: sum of 3 quarters · filed 2026-05-08 | $1.78M derived: sum of 4 quarters · filed 2026-05-08 | ||||||||
| 2024-12-31 | -$106.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.26M derived: sum of 2 quarters · filed 2026-03-31 | $1.23M derived: sum of 3 quarters · filed 2026-03-31 | $1.06M 10-K · filed 2026-03-31 | ||||||||
| 2024-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.34M derived: sum of 2 quarters · filed 2025-11-14 | $1.17M 10-Q · filed 2025-11-14 | $997.49K derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | -$28.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$200.94K 10-Q · filed 2025-08-12 | -$370.39K derived: sum of 3 quarters · filed 2025-08-12 | -$582.22K derived: sum of 4 quarters · filed 2025-08-12 | ||||||||
| 2024-03-31 | -$172.75K 10-Q · filed 2025-05-14 | -$342.20K derived: sum of 2 quarters · filed 2025-05-14 | -$554.03K derived: sum of 3 quarters · filed 2025-05-14 | $6.13M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||
| 2023-12-31 | -$169.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$381.28K derived: sum of 2 quarters · filed 2025-03-21 | $6.30M derived: sum of 3 quarters · filed 2025-03-21 | $6.64M 10-K · filed 2025-03-21 | ||||||||
| 2023-09-30 | -$211.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $6.47M derived: sum of 2 quarters · filed 2024-11-14 | $6.81M 10-Q · filed 2024-11-14 | $6.81M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||
| 2023-06-30 | $6.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $7.02M 10-Q · filed 2024-08-09 | $7.02M derived: sum of 3 quarters · filed 2024-08-09 | $6.94M derived: sum of 4 quarters · filed 2024-08-09 | ||||||||
| 2023-03-31 | $336.68K 10-Q · filed 2024-05-13 | $336.68K derived: sum of 2 quarters · filed 2024-05-13 | $250.99K derived: sum of 3 quarters · filed 2024-05-13 | $2.32M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2022-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$85.69K derived: sum of 2 quarters · filed 2024-03-22 | $1.99M derived: sum of 3 quarters · filed 2024-03-22 | $1.99M 10-K · filed 2024-03-22 | ||||||||
| 2022-09-30 | -$85.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.99M derived: sum of 2 quarters · filed 2023-11-09 | $1.99M 10-Q · filed 2023-11-09 | $2.02M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||
| 2022-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.07M 10-Q · filed 2023-08-10 | $2.10M derived: sum of 3 quarters · filed 2023-08-10 | $2.51M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $31.26K derived: sum of 2 quarters · filed 2023-05-11 | $437.62K derived: sum of 3 quarters · filed 2023-05-11 | $79.50K derived: sum of 4 quarters · filed 2023-05-11 | ||||||||
| 2021-12-31 | $31.26K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $437.62K derived: sum of 2 quarters · filed 2023-03-27 | $79.50K derived: sum of 3 quarters · filed 2023-03-27 | $28.30M 10-K · filed 2023-03-27 | ||||||||
| 2021-09-30 | $406.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $48.24K derived: sum of 2 quarters · filed 2022-11-10 | $28.26M 10-Q · filed 2022-11-10 | $31.20M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||
| 2021-06-30 | -$358.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $27.86M 10-Q · filed 2022-08-05 | $30.80M derived: sum of 3 quarters · filed 2022-08-05 | $35.88M derived: sum of 4 quarters · filed 2022-08-05 | ||||||||
| 2021-03-31 | $28.22M 10-Q · filed 2022-05-12 | $31.15M derived: sum of 2 quarters · filed 2022-05-12 | $36.24M derived: sum of 3 quarters · filed 2022-05-12 | $36.29M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||
| 2020-12-31 | $2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $8.02M derived: sum of 2 quarters · filed 2022-03-25 | $8.08M derived: sum of 3 quarters · filed 2022-03-25 | $17.69M 10-K · filed 2022-03-25 | ||||||||
| 2020-09-30 | $5.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $5.14M derived: sum of 2 quarters · filed 2021-11-04 | $14.76M 10-Q · filed 2021-11-04 | $17.13M derived: sum of 4 quarters · filed 2021-11-04 | ||||||||
| 2020-06-30 | $52.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $9.67M 10-Q · filed 2021-08-05 | $12.04M derived: sum of 3 quarters · filed 2021-08-05 | $11.84M derived: sum of 4 quarters · filed 2021-08-05 | ||||||||
| 2020-03-31 | $9.62M 10-Q · filed 2021-05-12 | $11.99M derived: sum of 2 quarters · filed 2021-05-12 | $11.79M derived: sum of 3 quarters · filed 2021-05-12 | $11.69M derived: sum of 4 quarters · filed 2021-05-12 | ||||||||
| 2019-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $2.17M derived: sum of 2 quarters · filed 2021-03-18 | $2.07M derived: sum of 3 quarters · filed 2021-03-18 | $3.58M 10-K · filed 2021-03-18 | ||||||||
| 2019-09-30 | -$204.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$304.65K derived: sum of 2 quarters · filed 2020-11-12 | $1.20M 10-Q · filed 2020-11-12 | $897.47K derived: sum of 4 quarters · filed 2020-11-12 | ||||||||
| 2019-06-30 | -$99.76K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-08-12 | $1.41M 10-Q · filed 2020-08-12 | $0.00 10-Q · filed 2019-07-17 | $1.10M derived: sum of 3 quarters · filed 2020-08-12 | $2.73M derived: sum of 4 quarters · filed 2020-08-12 | |||||||
| 2019-03-31 | $1.51M 10-Q/A · filed 2020-05-15 | $0.00 10-Q · filed 2019-05-01 | $1.20M derived: sum of 2 quarters · filed 2020-05-15 | $2.83M derived: sum of 3 quarters · filed 2020-05-15 | $2.89M derived: sum of 4 quarters · filed 2020-05-15 | |||||||
| 2018-12-31 | -$306.06K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $1.32M derived: sum of 2 quarters · filed 2020-03-23 | $1.38M derived: sum of 3 quarters · filed 2020-03-23 | $1.44M 10-K · filed 2020-03-23 | $118.01K 10-K · filed 2019-03-06 | |||||||
| 2018-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.69M derived: sum of 2 quarters · filed 2019-11-12 | $1.74M 10-Q · filed 2019-11-12 | $118.01K 10-Q · filed 2018-11-05 | $1.74M derived: sum of 4 quarters · filed 2019-11-12 | |||||||
| 2018-06-30 | $63.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-17 | $118.01K 10-Q · filed 2019-07-17 | $118.59K derived: sum of 3 quarters · filed 2019-07-17 | $118.59K derived: sum of 4 quarters · filed 2019-07-17 | ||||||||
| 2018-03-31 | $54.91K 10-Q · filed 2019-05-01 | $55.50K derived: sum of 2 quarters · filed 2019-05-01 | $55.50K derived: sum of 3 quarters · filed 2019-05-01 | $57.55K derived: sum of 4 quarters · filed 2019-05-01 | ||||||||
| 2017-12-31 | $585.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $585.00 derived: sum of 2 quarters · filed 2019-03-06 | $2.63K derived: sum of 3 quarters · filed 2019-03-06 | $2.63K 10-K · filed 2019-03-06 | ||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $2.05K derived: sum of 2 quarters · filed 2018-11-05 | $2.05K 10-Q · filed 2018-11-05 | $2.05K derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2017-06-30 | $2.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $2.05K 10-Q · filed 2018-08-01 | $2.05K derived: sum of 3 quarters · filed 2019-03-06 | $16.10K derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-02 | $2.00 derived: sum of 2 quarters · filed 2019-03-06 | $14.05K derived: sum of 3 quarters · filed 2019-03-06 | $14.50K derived: sum of 4 quarters · filed 2019-03-06 | ||||||||
| 2016-12-31 | $2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $14.05K derived: sum of 2 quarters · filed 2019-03-06 | $14.50K derived: sum of 3 quarters · filed 2019-03-06 | $22.10K 10-K · filed 2019-03-06 | ||||||||
| 2016-09-30 | $14.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $14.50K derived: sum of 2 quarters · filed 2017-11-06 | $22.10K 10-Q · filed 2017-11-06 | $24.05K derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2016-06-30 | $449.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $8.04K 10-Q · filed 2017-08-02 | $9.99K derived: sum of 3 quarters · filed 2018-03-07 | $13.37K derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2016-03-31 | $7.59K 10-Q · filed 2017-05-03 | $9.54K derived: sum of 2 quarters · filed 2018-03-07 | $12.92K derived: sum of 3 quarters · filed 2018-03-07 | $15.91K derived: sum of 4 quarters · filed 2018-03-07 | ||||||||
| 2015-12-31 | $1.95K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $5.32K derived: sum of 2 quarters · filed 2018-03-07 | $8.32K derived: sum of 3 quarters · filed 2018-03-07 | $80.84M 10-K · filed 2018-03-07 | ||||||||
| 2015-09-30 | $3.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $6.37K derived: sum of 2 quarters · filed 2016-11-02 | $80.84M 10-Q · filed 2016-11-02 | |||||||||
| 2015-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $80.84M 10-Q · filed 2016-08-03 | ||||||||||
| 2015-03-31 | $80.84M 10-Q · filed 2016-05-04 | |||||||||||
| 2014-12-31 | $40.41M 10-K · filed 2017-03-08 | |||||||||||
| 2014-06-30 | $39.52M 10-Q · filed 2015-11-04 | $15.58M 10-Q · filed 2015-08-05 | ||||||||||
| 2014-03-31 | $10.64M 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |